Loading...

Abbvie Inc (NYSE:ABBV)

152.34 USD +2.89 USD ( +1.93% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

EV/EBIT
Enterprise Value to EBIT

The Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
=
Enterprise Value
/
EBIT
Current EV/EBIT
ABBV
16.1
Median EV/EBIT
ABBV
15.6
Industry EV/EBIT
Biotechnology
2.2

EV/EBIT History

Statistics
Enterprise Value to EBIT

1 Year 3 Years 5 Years
Average 15.8 14.7 14.2
Median 15.8 15.6 14.3
Min 14 8.6 8.6
Max 19.3 21 21

History Chart
Enterprise Value to EBIT

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
10.4
2-Years Forward
EV/EBIT
12.1
3-Years Forward
EV/EBIT
12.2

EV/EBIT Across Competitors

ABBV Competitors
Abbvie Inc Competitors

Country Company Market Cap EV/EBIT
US
Abbvie Inc
NYSE:ABBV
269B USD 16.1
US
Amgen Inc
NASDAQ:AMGN
131B USD 20
AU
CSL Ltd
ASX:CSL
128B AUD 29.4
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD 7.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD 22.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
67.1B USD 6.9

Relative Valuation Report

View full relative valuation report for Abbvie Inc, which takes into account all ABBV`s valuation multiples.

See Also

Similar Stocks